{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:06:10Z","timestamp":1761419170445},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Korea Hemophilia Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-017-1720-0","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T10:42:06Z","timestamp":1503398526000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia"],"prefix":"10.1186","volume":"18","author":[{"given":"Young Shil","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Ju","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"1720_CR1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1302\/0301-620X.92B8.23922","volume":"92","author":"NJ Goddard","year":"2010","unstructured":"Goddard NJ, Mann HA, Lee CA. Total knee replacement in patients with endstage haemophilic arthropathy: 25-year results. J Bone Joint Surg Br. 2010;92:1085\u20139.","journal-title":"J Bone Joint Surg Br"},{"key":"1720_CR2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.arth.2013.07.014","volume":"29","author":"J Panotopoulos","year":"2014","unstructured":"Panotopoulos J, Ay C, Trieb K, Schuh R, Windhager R, Wanivenhaus HA. Outcome of total knee arthroplasty in hemophilic arthropathy. J Arthroplast. 2014;29:749\u201352.","journal-title":"J Arthroplast"},{"key":"1720_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2106\/JBJS.C.01609","volume":"87","author":"M Silva","year":"2005","unstructured":"Silva M, Luck JV Jr. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am. 2005;87:85\u201391.","journal-title":"J Bone Joint Surg Am"},{"key":"1720_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.knee.2013.09.010","volume":"21","author":"M Westberg","year":"2014","unstructured":"Westberg M, Paus AC, Holme PA, Tj\u00f8nnfjord GE. Haemophilic arthropathy: long-term outcomes in 107 primary total knee arthroplasties. Knee. 2014;21:147\u201350.","journal-title":"Knee"},{"key":"1720_CR5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2141.2000.02226.x","volume":"110","author":"A Batorova","year":"2000","unstructured":"Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol. 2000;110:715\u201320.","journal-title":"Br J Haematol"},{"key":"1720_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2141.1992.tb06951.x","volume":"82","author":"U Martinowitz","year":"1992","unstructured":"Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia a. Br J Haematol. 1992;82:729\u201334.","journal-title":"Br J Haematol"},{"issue":"Suppl. 1","key":"1720_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000204025","volume":"94","author":"UP Martinowitz","year":"1995","unstructured":"Martinowitz UP, Schulman S. Continuous infusion of factor concentrates: review of use in hemophilia a and demonstration of safety and efficacy in hemophilia B. Acta Haematol. 1995;94(Suppl. 1):35\u201342.","journal-title":"Acta Haematol"},{"key":"1720_CR8","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/hae.12530","volume":"21","author":"K Meijer","year":"2015","unstructured":"Meijer K, Rauchensteiner S, Santagostino E, Platokouki H, Schutgens RE, Brunn M, Tueckmantel C, Valeri F, Schinco PC. Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia a. Haemophilia. 2015;21:e19\u201325.","journal-title":"Haemophilia"},{"key":"1720_CR9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2516.2009.01986.x","volume":"15","author":"MC Yoo","year":"2009","unstructured":"Yoo MC, Cho YJ, Kim KI, Ramteke A, Chun YS. The outcome of cementless total hip arthroplasty in haemophilic hip arthropathy. Haemophilia. 2009;15:766\u201373.","journal-title":"Haemophilia"},{"key":"1720_CR10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.2830230405","volume":"23","author":"NA Rana","year":"1986","unstructured":"Rana NA, Shapiro GR, Green D. Long-term follow-up of prosthetic joint replacement in hemophilia. Am J Hematol. 1986;23:329\u201337.","journal-title":"Am J Hematol"},{"key":"1720_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1302\/0301-620X.70B3.3131346","volume":"70","author":"RP Karthaus","year":"1988","unstructured":"Karthaus RP, Novakova IR. Total knee replacement in haemophilic arthropathy. J Bone Joint Surg Br. 1988;70:382\u20135.","journal-title":"J Bone Joint Surg Br"},{"key":"1720_CR12","first-page":"98","volume":"248","author":"MP Figgie","year":"1989","unstructured":"Figgie MP, Goldberg VM, Figgie HE 3rd, Heiple KG, Sobel M. Total knee arthroplasty for the treatment of chronic hemophilic arthropathy. Clin Orthop Relat Res. 1989;248:98\u2013107.","journal-title":"Clin Orthop Relat Res"},{"key":"1720_CR13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2516.2002.00650.x","volume":"8","author":"D Dingli","year":"2002","unstructured":"Dingli D, Gastineau DA, Gilchrist GS, Nichols WL, Wilke JL. Continuous factor VIII infusion therapy in patients with haemophilia a undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates. Haemophilia. 2002;8:629\u201334.","journal-title":"Haemophilia"},{"key":"1720_CR14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2516.2011.02728.x","volume":"18","author":"JM Wong","year":"2012","unstructured":"Wong JM, Mann HA, Goddard NJ. Perioperative clotting factor replacement and infection in total knee arthroplasty. Haemophilia. 2012 Jul;18:607\u201312.","journal-title":"Haemophilia"},{"key":"1720_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.1970.tb01591.x","volume":"18","author":"CW McMillan","year":"1970","unstructured":"McMillan CW, Webster WP, Roberts HR, Blythe WB. Continuous intravenous infusion of factor VIII in classic haemophilia. Br J Haematol. 1970;18:659\u201367.","journal-title":"Br J Haematol"},{"key":"1720_CR16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.moh.0000239701.32674.e0","volume":"13","author":"A Batorova","year":"2006","unstructured":"Batorova A, Martinowitz U. Continuous infusion of coagulation factors: current opinion. Curr Opin Hematol. 2006;13:308\u201315.","journal-title":"Curr Opin Hematol"},{"key":"1720_CR17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2516.2010.02244.x","volume":"16","author":"H Takedani","year":"2010","unstructured":"Takedani H. Continuous infusion during total joint arthroplasty in Japanese haemophilia a patients: comparison study among two recombinants and one plasma-derived factor VIII. Haemophilia. 2010;16:740\u20136.","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"1720_CR18","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.5482\/HAMO-14-01-0004","volume":"34","author":"TA Wallny","year":"2014","unstructured":"Wallny TA, Strauss AC, Goldmann G, Oldenburg J, Wirtz DC, Pennekamp PH. Elective total knee arthroplasty in haemophilic patients. Proposal for a clinical pathway. Hamostaseologie. 2014;34(Suppl. 1):S23\u20139.","journal-title":"Hamostaseologie"},{"key":"1720_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.2830450305","volume":"45","author":"S Schulman","year":"1994","unstructured":"Schulman S, Gitel S, Martinowitz U. Stability of factor VIII concentrates after reconstitution. Am J Hematol. 1994;45:217\u201323.","journal-title":"Am J Hematol"},{"key":"1720_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-0038-1648879","volume":"72","author":"S Schulman","year":"1994","unstructured":"Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost. 1994;72:403\u20137.","journal-title":"Thromb Haemost"},{"issue":"Suppl. 3","key":"1720_CR21","first-page":"1","volume":"12","author":"M Lee","year":"2006","unstructured":"Lee M, Morfini M, Negrier C, Chamouard V. The pharmacokinetics of coagulation factors. Haemophilia. 2006;12(Suppl. 3):1\u20137.","journal-title":"Haemophilia"},{"key":"1720_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00003086-200111000-00003","volume":"392","author":"G Peersman","year":"2001","unstructured":"Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001;392:15\u201323.","journal-title":"Clin Orthop Relat Res"},{"key":"1720_CR23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2516.2008.01978.x","volume":"15","author":"U Martinowitz","year":"2009","unstructured":"Martinowitz U, Luboshitz J, Bashari D, Ravid B, Gorina E, Regan L, Stass H, Lubetsky A. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia. 2009;15:676\u201385.","journal-title":"Haemophilia"},{"key":"1720_CR24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00167-011-1766-8","volume":"20","author":"M Rahm\u00e9","year":"2012","unstructured":"Rahm\u00e9 M, Ehlinger M, Faradji A, Gengenwin N, Lecocq J, Sibilia J, Bonnomet F. Total knee arthroplasty in severe haemophilic patients under continuous infusion of clotting factors. Knee Surg Sports Traumatol Arthrosc. 2012;20:1781\u20136.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"1720_CR25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/hae.12075","volume":"19","author":"G Auerswald","year":"2013","unstructured":"Auerswald G, Bade A, Haubold K, Overberg D, Masurat S, Moorthi C. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study. Haemophilia. 2013;19:438\u201344.","journal-title":"Haemophilia"},{"key":"1720_CR26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/17474086.2013.856261","volume":"6","author":"EC Rodriguez-Merchan","year":"2013","unstructured":"Rodriguez-Merchan EC. Special features of total knee replacement in hemophilia. Expert Rev Hematol. 2013;6:637\u201342.","journal-title":"Expert Rev Hematol"},{"key":"1720_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1096-8652(199909)62:1<13::AID-AJH3>3.0.CO;2-X","volume":"62","author":"AF Belgaumi","year":"1999","unstructured":"Belgaumi AF, Patrick CC, Deitcher SR. Stability and sterility of a recombinant factor VIII concentrate prepared for continuous infusion administration. Am J Hematol. 1999;62:13\u20138.","journal-title":"Am J Hematol"},{"key":"1720_CR28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1196\/annals.1361.094","volume":"1051","author":"C Auer von","year":"2005","unstructured":"von Auer C, Oldenburg J, von Depka M, Escuriola-Ettinghausen C, Kurnik K, Lenk H, Scharrer I. Inhibitor development in patients with hemophilia a after continuous infusion of FVIII concentrates. Ann N Y Acad Sci. 2005;1051:498\u2013505.","journal-title":"Ann N Y Acad Sci"},{"key":"1720_CR29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2141.2012.09119.x","volume":"157","author":"CL Eckhardt","year":"2012","unstructured":"Eckhardt CL, Mauser-Bunschoten EP, Peters M, Leebeek FW, van der Meer FJ, Fijnvandraat K. Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia a: a prospective national study in the Netherlands. Br J Haematol. 2012;157:747\u201352.","journal-title":"Br J Haematol"},{"key":"1720_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1423-0410.2012.01653.x","volume":"104","author":"Y Chevalier","year":"2013","unstructured":"Chevalier Y, Dargaud Y, Lienhart A, Chamouard V, Negrier C. Seventy-two total knee arthroplasties performed in patients with haemophilia using continuous infusion. Vox Sang. 2013;104:135\u201343.","journal-title":"Vox Sang"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-017-1720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T13:35:05Z","timestamp":1570023305000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-017-1720-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1186\/s12891-017-1720-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"article-number":"356"}}